- 16 set.- 15:40

VALBIOTIS Presents Positive Results From a Study on TOTUM-63, Active Substance of VALEDIA®, Conducted by the CarMeN Laboratory in Lyon, at the Annual Meeting of the European Association for the Study of Diabetes (EASD)

Business Wire.
  • This preclinical study conducted by the CarMeN laboratory, expert in metabolic diseases, confirms the major effects of the active substance TOTUM-63 on weight and glucose metabolism.
  • Data demonstrates capacity of TOTUM-63 to significantly correct the secretion of three hormones, essential for blood glucose regulation (insulin, glucagon and GLP-1) in a preclinical model of metabolic disease.
  • These results have been selected for presentation at the 55th EASD Annual Meeting which will be held September 16-20, 2019 in Barcelona.

Video Economia

Vai alla rubrica Risparmio e Investimenti
Vai al sito: ANSA Professioni

Vai al sito: L'Agenda Economica Finanziaria e Rassegna Stampa dell'ANSA
Vai alla rubrica: Pianeta Camere
Vai alla rubrica: Pianeta Camere

Criptovalute news


Piani Individuali di Risparmio

Frenata lancio prodotti. Da nuove norme possibili perdite